Amikacin 250 mg Injection – Brands in India, Manufacturer & PCD Franchise (Amiza-250)



Amikacin-250 mg (2 ml) Injection — made for Trumac Healthcare at WHO-GMP certified partner units

Amikacin-250 mg (2 ml) Injection

PCD Pharma Franchise Supplier in India · Made at WHO-GMP Partner Units

Salt: Amikacin-250 mg (2 ml)
Form: Injection
Class: Aminoglycoside Antibiotic
✓ WHO-GMP
✓ Pan-India Monopoly PCD
✓ 1 Brand Options

Pricing, brochure & monopoly territory within 24 hrs.


For chemists, distributors and doctors: Amiza-250 (amikacin 250 mg / 2 ml injection (IV/IM)) is available from Trumac Healthcare on a PCD franchise with monopoly rights for your district, and as wholesale stock for licensed distributors. No franchise fee; first order from ₹25,000 – work out your margin with the PTR / PTS calculator.

WhatsApp for price list & availability

Our Amikacin-250 mg (2 ml) Injection Brand Options (1 option)

Trumac Healthcare supplies the following Amikacin-250 mg (2 ml) Injection brands for PCD pharma distribution. Click any brand to view full specifications and packaging.

Amikacin-250 mg (2 ml) Injection is made at WHO-GMP certified partner units and supplied by Trumac Healthcare for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Amikacin-250 mg (2 ml) formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.

Offered by Trumac Healthcare, a PCD pharma franchise company, available on a monopoly basis – see the critical care pharma franchise product list (PDF). Comparing companies? See the injectable PCD companies compared. No franchise fee; minimum first order ₹25,000 – cost and documents.


Amikacin 250 mg injection Brands in India – Amiza-250 for PCD Franchise & Wholesale

Looking for amikacin 250 mg injection brands in India? Trumac Healthcare markets amikacin 250 mg injection as Amiza-250, made at WHO-GMP certified partner units, on a monopoly PCD franchise basis and as wholesale stock across India. The aminoglycoside injection physicians and paediatricians use for serious hospital infections such as sepsis, pneumonia and urinary infections, often with a beta-lactam; 100 mg and 500 mg cover other doses.

It is part of the injectable & critical care PCD franchise range. Trumac Healthcare has worked since 2007 and supplies more than 4000 franchise partners; no franchise fee, minimum first order ₹25,000.

Related brands

Ways to work with us

  • PCD pharma franchise – amikacin 250 mg injection under our brand on a monopoly basis for your area, with visual aids and promotional material
  • Wholesale supply – stock for distributors, stockists and hospital suppliers across India, against drug licence and GST
  • Own-brand (third-party) enquiries – share the composition, pack and quantity and we will confirm availability and send a quotation

How to start

  1. Send your requirement on WhatsApp – product, franchise or wholesale, quantity and your area
  2. Receive the price list and monopoly terms (no franchise fee; minimum first order ₹25,000)
  3. Confirm the order and pay by NEFT, RTGS or IMPS
  4. Goods are dispatched once payment reflects, with the docket number for tracking

Questions buyers ask

Which amikacin 250 mg injection brands are available in India for PCD franchise?

Amiza-250 from Trumac Healthcare, made at WHO-GMP certified partner units, on a monopoly PCD franchise basis across India.

Do you supply amikacin 250 mg injection wholesale?

Yes, to distributors and stockists with a valid drug licence. Share quantity and location for the rate.

Which division is it part of?

The injectable & critical care division, which can be taken alone on monopoly for your district.

Can I get amikacin 250 mg injection under my own brand?

Share your brand name, pack and quantity on WhatsApp and we will confirm availability and send a quotation.

Enquiry: Share your amikacin 250 mg injection requirement – franchise or wholesale, with strength, quantity and location. WhatsApp +91 90416 77932.

Therapeutic Indications
  • Serious gram-negative bacterial infections — septicaemia, complicated UTI
  • Hospital-acquired pneumonia and ventilator-associated pneumonia
  • Complicated intra-abdominal infections (with beta-lactam)
  • Skin, soft tissue and post-surgical infections
  • Empirical therapy in febrile neutropenia
  • Adjunct in multi-drug-resistant tuberculosis
Mechanism of Action

Amikacin binds irreversibly to the 30S bacterial ribosomal subunit, causing mRNA misreading and inhibition of protein synthesis. The resulting non-functional proteins damage bacterial cell membranes, producing rapid bactericidal effect. Activity is concentration-dependent with a long post-antibiotic effect supporting once-daily dosing.

Dosage & Administration
  • Adults: 15 mg/kg/day, typically given as a single daily dose by IM injection or slow IV infusion.
  • Dose adjustment required in renal impairment based on serum levels.
  • Treatment duration typically 7–10 days.
Side Effects
  • Nephrotoxicity, ototoxicity (cochlear and vestibular), neuromuscular blockade.
  • Local injection site pain.
  • Less commonly: hypersensitivity, rash, transient hepatic enzyme elevation.
Contraindications
  • Hypersensitivity to aminoglycosides.
  • Concomitant nephrotoxic/ototoxic drugs without monitoring.
  • Pre-existing 8th cranial nerve damage.
  • Myasthenia gravis.
  • Pregnancy (Category D).
  • Therapeutic drug monitoring strongly advised in renal impairment.
Storage

Store below 25 °C, protected from light. Do not freeze.

PCD Pharma Franchise for Amikacin-250 mg (2 ml) Injection

  • ✓ Made at WHO-GMP certified partner units
  • ✓ Pan-India monopoly distribution rights available
  • ✓ Multiple pack sizes: Vial
  • ✓ Trade-friendly PTR / PTS margins
  • ✓ Free promotional material on request
  • ✓ Full DCGI documentation and quality certificates supplied

Trumac Healthcare offers 1 brand option for Amikacin-250 mg (2 ml) Injection — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.

For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Amikacin-250 mg (2 ml) Injection, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.

Frequently Asked Questions

Who is the manufacturer of Amikacin-250 mg (2 ml) Injection?

Trumac Healthcare markets Amikacin-250 mg (2 ml) Injection made at WHO-GMP certified partner manufacturing units in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.

Is Amikacin-250 mg (2 ml) Injection available for PCD pharma franchise on monopoly basis?

Yes. We offer Amikacin-250 mg (2 ml) Injection for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.

What pack sizes are available for Amikacin-250 mg (2 ml) Injection?

Available pack sizes include: Vial.

What is the MRP / trade price for Amikacin-250 mg (2 ml) Injection?

MRPs range from ₹85 to ₹85 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.

How do I place an order or franchise enquiry?

WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.

Ready to start your PCD franchise for Amikacin-250 mg (2 ml) Injection?

Get Pricing & Franchise Terms →